Robert Mabry, Hillstar Bio CEO

An­oth­er im­munol­o­gy biotech emerges as Hill­star takes flight with $67M

The flur­ry of im­munol­o­gy biotech launch­es con­tin­ues.

Boston-based Hill­star Bio on Tues­day be­came the lat­est im­munol­o­gy start­up launch, un­veil­ing a $67 mil­lion Se­ries A round …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.